Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Retro Fitness, NFFF Partner for 9/11 Memorial Stair Climbs
- Study ranks Alabama among worst states for children’s nutrition
- Measuring Beyond the Machine
- Peta Murgatroyd Placed Family’s Well
- ‘Biased’ Channel 4 programme on ADHD misrepresented my views, says expert
- Why rapid weight loss can make you look older
- As a doctor, I’m fighting in Congress to lower health costs
- New Orleans women focus on health and connection at ‘Shake Back’ fit camp
Browsing: Weight Loss
Bank of America spends more than $250 million a year covering GLP-1 weight loss drugs for its employees, CEO Brian Moynihan told CNBC on Wednesday, saying the rapidly rising cost is a worthwhile investment in his workforce
Weeks of speculation surrounding Salman Khan’s noticeably lean appearance have finally come to an end. The Bollywood superstar has confirmed that his dramatic transformation was intentional, revealing that he has lost 16 kilograms as part of his fitness journey, putting rumours about his health to rest
From social media claims to questions about safety, UConn Health OB/GYN and obesity medicine specialist Dr. Jason Schneider explains what patients should really know
Is Eli Lilly’s up-and-coming obesity medicine a biologic? The FDA doesn’t appear to think so, and that opinion could shape how the company can file the potential blockbuster for approval and the years of market exclusivity that will follow
From social media claims to questions about safety, UConn Health OB/GYN and obesity medicine specialist Dr. Jason Schneider explains what patients should really know
CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit Aetna shows signs of recovery.
After the company reported second quarter earnings and raised its full-year sales guidance, Eli Lilly (LLY) CFO Lucas Montarce outlines the expansion opportunities that the pharmaceutical giant is seeing in its GLP-1 category, specifically the introduction of oral weight-loss drugs to the market
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro surged again
As the GLP-1 Era Reshapes Weight Management, METAbiotics Launches with Science Designed to Support Long-Term Success
Hers, a digital healthcare platform that provides virtual care and prescriptions, is expanding its services by adding a built-in AI tool to its app. The AI feature uses information from the patient’s medical history and connects them to a provider for additional personalized support. Hers is first focusing on weight loss patients and those on GLP-1…

